Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Febuxostat may be superior to allopurinol in treating hyperuricemia and gout

Dec. 28, 2005

Neose Technologies updates NE-180 program

Dec. 28, 2005

Acetyl-CoA carboxylase inhibitors emerge from Ajinomoto R&D

Dec. 28, 2005

Recent patents report new therapeutic agents for diabetes and other endocrine-related disorders

Dec. 27, 2005

Bristol-Myers Squibb and Merck & Co. terminate muraglitazar agreement

Dec. 27, 2005

Exelixis and Wyeth sign licensing agreement for compounds targeting FXR

Dec. 27, 2005

CuraGen and Bayer amend terms in metabolic disorder collaboration

Dec. 22, 2005

Fast track designation for C1-INH in hereditary angioedema

Dec. 22, 2005

New data on AMG-531 in immune thrombocytopenic purpura reported

Dec. 21, 2005

TLK-199 induces responses in myelodysplastic syndrome patients

Dec. 21, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...